We're taking a closer look at Perrigo Company today, as the chatter surrounding the stock has increased notably in the last few weeks. Today, its shares moved -1.8% compared to 1.0% for the S&P 500. Increased investor interest and volatility surrounding the stock are not reason enough to buy in -- you should first perform your own due diligence. Here are some figures that can get you started:
-
Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in Ireland, the United States, France, Belgium, China, the United Kingdom, Germany, Switzerland, Austria, Italy, Australia, Greece, and Spain.
-
Perrigo Company has moved 13.7% over the last year compared to -1.5% for the S&P 500 -- a difference of 15.0%
-
PRGO has an average analyst rating of buy and is -28.84% away from its mean target price of $51.0 per share
-
Its trailing 12 month earnings per share (EPS) is $-0.96
-
Perrigo Company has a trailing 12 month Price to Earnings (P/E) ratio of -37.8 while the S&P 500 average is 15.97
-
Its forward earnings per share (EPS) is $3.08 and its forward P/E ratio is 11.8
-
PRGO has a Price to Earnings Growth (PEG) ratio of 1.4, which shows the company is fairly valued compared to its earnings.
-
The company has a Price to Book (P/B) ratio of 1.01 in contrast to the S&P 500's average ratio of 2.95
-
Perrigo Company is part of the Health Care sector, which has an average P/E ratio of 24.45 and an average P/B of 4.16
-
Perrigo Company has on average reported free cash flows of $232.75 Million over the last four years, during which time they have grown by an an average of -4.2%